Longitudinal evaluation of surrogates of regional cerebral blood flow computed from dynamic amyloid PET imaging

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Longitudinally and inter-site consistent multi-atlas based parcellation of brain anatomy using harmonized atlases

(2018) Guray Erus et al.   NEUROIMAGE

Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia

(2018) Yujing Zhao et al.   JAMA Neurology

Evaluation of early-phase [ 18 F]-florbetaben PET acquisition in clinical routine cases

(2017) Sonja Daerr et al.   NeuroImage-Clinical

Early [18F]florbetaben and [11C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease

(2016) Solveig Tiepolt et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease

(2016) E. Rodriguez-Vieitez et al.   JOURNAL OF NUCLEAR MEDICINE

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study

(2016) Samantha C Burnham et al.   LANCET NEUROLOGY

MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection

(2016) Jimit Doshi et al.   NEUROIMAGE

Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change

(2016) Anja Soldan et al.   JAMA Neurology

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET

(2015) Y. J. Chen et al.   JOURNAL OF NUCLEAR MEDICINE

Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent manner

(2015) Anton F. Gietl et al.   NEUROBIOLOGY OF AGING

Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis

(2014) Liping Fu et al.   EUROPEAN RADIOLOGY

Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals

(2014) Elizabeth C. Mormino et al.   JAMA Neurology

The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly

(2013) Miranka Wirth et al.   Alzheimers & Dementia

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

(2013) Victor L Villemagne et al.   LANCET NEUROLOGY

Washout allometric reference method (WARM) for parametric analysis of [11C]PIB in human brains

(2013) Anders Rodell et al.   Frontiers in Aging Neuroscience

Blood-brain transfer of Pittsburgh compound B in humans

(2013) Albert Gjedde et al.   Frontiers in Aging Neuroscience

Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies

(2012) Ing-Tsung Hsiao et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The use of PIB-PET as a dual pathological and functional biomarker in AD

(2011) Anton Forsberg et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B

(2011) P. T. Meyer et al.   JOURNAL OF NUCLEAR MEDICINE

Cerebral Blood Flow Response to Functional Activation

(2009) Olaf B Paulson et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

(2009) Susan M. Landau et al.   NEUROBIOLOGY OF AGING

PET radiotracers: crossing the blood–brain barrier and surviving metabolism

(2009) Victor W. Pike   TRENDS IN PHARMACOLOGICAL SCIENCES